Updated Dec. 19, 2012 at 9:58 a.m.

Premium Lock C.H.-based drug firm Cempra launches Phase 3 trial

Published: 2012-12-19 09:49:00
Updated: 2012-12-19 09:58:02

Print this blog post
Cempra Cempra

Anitbiotics developer Cempra Pharmaceuticals (Nasdaq: CEMP), which in October completed a $25 million private placement of additional shares, has launched a new clinical trial....



Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll